Cancer

Inspired by natural biomineralisation processes, a novel cancer therapy uses gold nanoparticles to selectively sabotage vital components in cancer cells.

A new machine learning tool could help predict cancer treatment outcomes for more effective and targeted treatments.

High iron levels, often linked to red meat consumption, can fuel cancer growth by reactivating proteins that allow cancer cells to divide endlessly.

A new sensor innovation measures stress inside tissue models to simulate disease conditions like cancer with greater accuracy.

Innovative designer molecules called stapled peptides effectively target and block cancer processes, promising a new therapeutic approach.

As the immune system ages, our susceptibility to conditions such as cancer increases, prompting researchers to develop advanced experimental models to study these pathways.

Researchers find that targeting nerve growth factor in melanomas transforms resistant ‘cold’ tumours into treatable ‘hot’ ones, adding new therapeutic options for challenging skin cancers.

A*STAR researchers developed specially designed nanocomplexes that effectively target and kill cancer cells, including those resistant to traditional treatments.

Researchers develop a new technology for studying how brain tumours interact with the blood-brain barrier to inform future treatment strategies.

Researchers identify predictive immune ‘signatures’ in liver cancer patients that can help tailor and improve the success rates of combined immunotherapy and radiotherapy.

Researchers reveal how disrupting a key genetic control mechanism can significantly hinder the progression and spread of an aggressive and difficult-to-treat form of breast cancer.

Unique gene signatures associated with drug-resistant leukaemia paves the way for improved clinical strategies to help these patients.